Perrin Justine, Farid Karim, Van Parijs Hilde, Gorobets Olena, Vinh-Hung Vincent, Nguyen Nam P, Djassemi Navid, De Ridder Mark, Everaert Hendrik
Nuclear Medicine, CHU de Martinique, Fort-de-France 97200, Martinique.
Department of Radiotherapy, UZ Brussel, Brussels 1090, Belgium.
World J Clin Oncol. 2022 Apr 24;13(4):287-302. doi: 10.5306/wjco.v13.i4.287.
The prognostic value of preoperative fluorine-18-fluorodeoxyglucose positron-emission tomography (F-FDG PET) scan for determining overall survival (OS) in breast cancer (BC) patients is controversial.
To evaluate the OS predictive value of preoperative PET positivity after 15 years.
We performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between 2002-2008. PET positivity was determined by anatomical region of interest (AROI) findings for breast and axillary, sternal, and distant sites. The prognostic role of PET was examined as a qualitative binary factor (positive negative status) and as a continuous variable [maximum standard uptake value (SUVmax)] in multivariate survival analyses using Cox proportional hazards models. Among the 104 identified patients who received PET, 36 were further analyzed for the SUVmax in the AROI.
Poor OS within the 15-year study period was predicted by PET-positive status for axillary ( = 0.033), sternal ( = 0.033), and combined PET-axillary/sternal ( = 0.008) nodes. Poor disease-free survival was associated with PET-positive axillary status ( = 0.040) and combined axillary/sternal status ( = 0.023). Cox models confirmed the long-term prognostic value of combined PET-axillary/sternal status [hazard ratio (HR): 3.08, 95% confidence interval: 1.42-6.69]. SUVmax of ipsilateral breast and axilla as continuous covariates were significant predictors of long-term OS with HRs of 1.25 ( = 0.048) and 1.54 ( = 0.029), corresponding to relative increase in the risk of death of 25% and 54% per SUVmax unit, respectively. In addition, the ratio of the ipsilateral axillary SUVmax over the contralateral axillary SUVmax was the most significant OS predictor ( = 0.027), with 1.94 HR, indicating a two-fold relative increase of mortality risk.
Preoperative PET is valuable for prediction of long-term survival. Ipsilateral axillary SUVmax ratio over the uninvolved side represents a new prognostic finding that warrants further investigation.
术前氟-18-氟脱氧葡萄糖正电子发射断层扫描(F-FDG PET)对确定乳腺癌(BC)患者总生存期(OS)的预后价值存在争议。
评估15年后术前PET阳性对总生存期的预测价值。
我们对布鲁塞尔大学医院患者数据库进行了回顾性检索,以查找2002年至2008年间接受术前PET检查的非转移性患者。PET阳性通过乳腺、腋窝、胸骨和远处部位的感兴趣解剖区域(AROI)结果来确定。在使用Cox比例风险模型的多变量生存分析中,将PET的预后作用作为定性二元因素(阳性/阴性状态)和连续变量[最大标准摄取值(SUVmax)]进行检验。在104例接受PET检查的已识别患者中,对36例患者的AROI中的SUVmax进行了进一步分析。
腋窝(P = 0.033)、胸骨(P = 0.033)以及PET腋窝/胸骨联合阳性(P = 0.008)的患者在15年研究期内的总生存期较差。无病生存期较差与PET腋窝阳性状态(P = 0.040)和腋窝/胸骨联合阳性状态(P = 0.023)相关。Cox模型证实了PET腋窝/胸骨联合阳性状态的长期预后价值[风险比(HR):3.08,95%置信区间:1.42 - 6.69]。同侧乳腺和腋窝的SUVmax作为连续协变量是长期总生存期的显著预测因素,HR分别为1.25(P = 0.048)和1.54(P = 0.029),分别对应每单位SUVmax死亡风险相对增加25%和54%。此外,同侧腋窝SUVmax与对侧腋窝SUVmax的比值是最显著的总生存期预测因素(P = 0.027),HR为1.94,表明死亡风险相对增加两倍。
术前PET对预测长期生存有价值。同侧腋窝与未受累侧的SUVmax比值代表了一个新的预后发现,值得进一步研究。